GNPX Genprex, Inc.
$1.77▼ -2.49%
Healthcare
Other
Volume 22.2K
Avg Volume (10D) 201.3K
Key Metrics & Fundamentals
Market Cap
$1.45M
P/E Ratio
0.1
Div Yield
0.00%
52W Range
1.72 - 217.60
% vs 50 MA
-42.20%
% vs 200 MA
-91.58%
RSI-14
21.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.18
Free Cash Flow
-$5.14M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.48M
COGS
–
Operating Exp
$4.48M
Operating Income
-$4.48M
EBIT
-$4.48M
Pretax Income
-$4.45M
Net Income
-$4.45M
EPS (Diluted)
-9.40
Price & Volume History
Loading chart…
Recent News
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
PR Newswire · Oct 21, 2026 7:00 AM ET
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 8:00 AM ET
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
PR Newswire · Sep 1, 2026 8:00 AM ET
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
PR Newswire · Aug 18, 2026 7:00 AM ET
Genprex Shares Rise After Collaboration With Roche Diagnostics
InvestorsHub · Aug 3, 2026 8:46 AM ET
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
PR Newswire · Aug 3, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See GNPX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.